Long-term Cohort Study of Mesorectal Excision for Rectal Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Study summary

The aim of this cohort study is to record, evaluate and compare the surgical, oncological as well as the functional outcome and Quality of life after mesorectal excision for rectal cancer

Eligibility

Primary outcome measure(s)

• Perioperative mortality — 90 days
  Reporting perioperative mortality with Clavien-Dindo \& Comprehensive Complications Index
• Age — 10 years
  Age (years)
• Body mass index — 10 years
  BM (kg/m2)
• Gender — 10 years
  Sex (male, female)
• ASA score — 10 years
  American Society of Anesthesiologists score (I to V)
• Date of surgery — day of surgery
  date of surgery (day-month-year)
• Tumor localisation — 10 years
  Description of tumor localisation
• Comorbidities — day of surgery
  Charlson index
• Perioperative complications — 90 days
  Reporting and grading of postoperative surgical complications (according to Dindo-Clavien classification and/or comprehensive complications index)
• Histological results — 30 days
  Histological staging and grading of the specimen by a pathologist
• Quality of life, including functional and symptom scales, incontinence scores, sexual function — 10 years
  taTME survey (validated english, german, french versions); from 0 (worst) to 100 (best)

Trial sites (1)

More Kantonsspital Winterthur KSW trials in Switzerland

Other trials for the same condition